Truist lowered the firm’s price target on Confluent (CFLT) to $27 from $30 but keeps a Buy rating on the shares after its Q2 results. Despite modest upside in the quarter, the management reiterated the high end of the subscription revenue outlook for the year, as optimization offset other positive catalysts, the analyst tells investors in a research note. At current levels, the share price does not reflect any confidence in the potential drivers of reacceleration that management continues to highlight from AI, the firm added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT:
